Tiludronic-acid | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | |
Tiludronic-acid | hsa00190 | Oxidative phosphorylation | 2.67E-03 | 4 | Q16718, Q13488, Q9Y5K8, O14521 | NDUFA5, TCIRG1, ATP6V1D, SDHD | More | |
Tiludronic-acid | hsa00280 | Valine, leucine and isoleucine degradation | 1.67E-02 | 4 | P55809, Q9HCC0, Q02252, P11310 | OXCT1, MCCC2, ALDH6A1, ACADM | More | |
Tiludronic-acid | hsa00561 | Glycerolipid metabolism | 2.55E-03 | 5 | O14494, P14550, P06280, P23743, Q86XP1 | PLPP1, AKR1A1, GLA, DGKA, DGKH | More | |
Tiludronic-acid | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | |
Tiludronic-acid | hsa00600 | Sphingolipid metabolism | 3.96E-02 | 3 | Q9BX95, O14494, P06280 | SGPP1, PLPP1, GLA | More | |
Tiludronic-acid | hsa01210 | 2-Oxocarboxylic acid metabolism | 3.43E-02 | 1 | P50213 | IDH3A | More | |
Tiludronic-acid | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | |
Tiludronic-acid | hsa04141 | Protein processing in endoplasmic reticulum | 2.78E-02 | 3 | P07384, O95487, O95816 | CAPN1, SEC24B, BAG2 | More | |
Tiludronic-acid | hsa04145 | Phagosome | 2.47E-02 | 7 | P60709, Q15075, Q15080, P14598, Q13509, Q13488, Q9Y5K8 | ACTB, EEA1, NCF4, NCF1, TUBB3, TCIRG1, ATP6V1D | More | |
Tiludronic-acid | hsa04150 | mTOR signaling pathway | 2.32E-02 | 1 | Q9Y5K8 | ATP6V1D | More | |
Tiludronic-acid | hsa04151 | PI3K-Akt signaling pathway | 2.22E-02 | 9 | Q08999, P20827, Q13362, P08238, P62873, P16144, P01568, P10415, P17252 | RBL2, EFNA1, PPP2R5C, HSP90AB1, GNB1, ITGB4, IFNA21, BCL2, PRKCA | More | |
Tiludronic-acid | hsa04217 | Necroptosis | 4.64E-03 | 7 | P01568, Q13489, P42224, P08238, Q6FI13, P10415, O43633 | IFNA21, BIRC3, STAT1, HSP90AB1, H2AC18; H2AC19, BCL2, CHMP2A | More | |
Tiludronic-acid | hsa04218 | Cellular senescence | 6.34E-03 | 5 | P30281, P10145, P01889, P10321, P12236 | CCND3, IL8, HLA-B, HLA-C, SLC25A6 | More | |
Tiludronic-acid | hsa04360 | Axon guidance | 1.50E-02 | 3 | P20827, P23528, Q06124 | EFNA1, CFL1, PTPN11 | More | |
Tiludronic-acid | hsa04530 | Tight junction | 2.08E-02 | 3 | P63261, Q9Y478, Q92974 | ACTG1, PRKAB1, ARHGEF2 | More | |
Tiludronic-acid | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | |
Tiludronic-acid | hsa04621 | NOD-like receptor signaling pathway | 4.52E-02 | 6 | P08238, P42224, P01568, P25963, Q13489, P10415 | HSP90AB1, STAT1, IFNA21, NFKBIA, BIRC3, BCL2 | More | |
Tiludronic-acid | hsa04623 | Cytosolic DNA-sensing pathway | 2.27E-02 | 2 | P01568, P25963 | IFNA21, NFKBIA | More | |
Tiludronic-acid | hsa04630 | JAK-STAT signaling pathway | 4.82E-02 | 5 | P10415, P42224, P29350, P40189, P01568 | BCL2, STAT1, PTPN6, IL6ST, IFNA21 | More | |
Tiludronic-acid | hsa04714 | Thermogenesis | 1.25E-02 | 3 | P15336, P63261, Q9Y478 | ATF2, ACTG1, PRKAB1 | More | |
Tiludronic-acid | hsa04721 | Synaptic vesicle cycle | 8.29E-03 | 1 | Q9Y5K8 | ATP6V1D | More | |
Tiludronic-acid | hsa04920 | Adipocytokine signaling pathway | 2.80E-02 | 2 | Q06124, Q9Y478 | PTPN11, PRKAB1 | More | |
Tiludronic-acid | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.87E-02 | 4 | P42224, P10415, Q12778, P17252 | STAT1, BCL2, FOXO1, PRKCA | More | |
Tiludronic-acid | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | |
Tiludronic-acid | hsa04966 | Collecting duct acid secretion | 4.60E-04 | 2 | Q9Y5K8, P00918 | ATP6V1D, CA2 | More | |
Tiludronic-acid | hsa05110 | Vibrio cholerae infection | 3.63E-05 | 7 | Q13488, Q9Y5K8, Q99437, P17252, P19174, P17612, P60709 | TCIRG1, ATP6V1D, ATP6V0B, PRKCA, PLCG1, PRKACA, ACTB | More | |
Tiludronic-acid | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 9.23E-04 | 4 | Q9Y5K8, Q99437, P10145, P41240 | ATP6V1D, ATP6V0B, IL8, CSK | More | |
Tiludronic-acid | hsa05130 | Pathogenic Escherichia coli infection | 9.80E-03 | 4 | Q92974, P63261, Q06124, O95487 | ARHGEF2, ACTG1, PTPN11, SEC24B | More | |
Tiludronic-acid | hsa05132 | Salmonella infection | 1.94E-02 | 7 | P25963, P08238, Q13489, P10415, Q13561, P68371, P49754 | NFKBIA, HSP90AB1, BIRC3, BCL2, DCTN2, TUBB2C, VPS41 | More | |
Tiludronic-acid | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | |
Tiludronic-acid | hsa05140 | Leishmaniasis | 1.26E-03 | 5 | P14598, P42224, P25963, P29350, Q15080 | NCF1, STAT1, NFKBIA, PTPN6, NCF4 | More | |
Tiludronic-acid | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | |
Tiludronic-acid | hsa05144 | Malaria | 3.09E-02 | 2 | P69905, P68871 | HBA2, HBB | More | |
Tiludronic-acid | hsa05152 | Tuberculosis | 4.05E-02 | 5 | Q13488, P42224, P10415, P01568, Q9UDY8 | TCIRG1, STAT1, BCL2, IFNA21, MALT1 | More | |
Tiludronic-acid | hsa05165 | Human papillomavirus infection | 5.13E-03 | 13 | P16144, Q08999, P30281, Q9UM47, P01568, P42224, P01889, P10321, Q13488, Q99437, P17612, Q13362, Q12778 | ITGB4, RBL2, CCND3, NOTCH3, IFNA21, STAT1, HLA-B, HLA-C, TCIRG1, ATP6V0B, PRKACA, PPP2R5C, FOXO1 | More | |
Tiludronic-acid | hsa05168 | Herpes simplex virus 1 infection | 8.71E-03 | 10 | P25963, P01568, P42224, Q07955, Q13243, Q13489, Q13398, O75820, Q9UDV6, P10415 | NFKBIA, IFNA21, STAT1, SFRS1, SFRS5, BIRC3, ZNF211, ZNF189, ZNF212, BCL2 | More | |
Tiludronic-acid | hsa05170 | Human immunodeficiency virus 1 infection | 2.67E-02 | 7 | P62873, P17252, P01568, P25963, P23528, P10415, Q13619 | GNB1, PRKCA, IFNA21, NFKBIA, CFL1, BCL2, CUL4A | More | |
Tiludronic-acid | hsa05203 | Viral carcinogenesis | 1.06E-02 | 5 | P30281, P06396, P01889, P10321, P17612 | CCND3, GSN, HLA-B, HLA-C, PRKACA | More | |
Tiludronic-acid | hsa05211 | Renal cell carcinoma | 1.06E-02 | 2 | Q06124, Q99814 | PTPN11, EPAS1 | More | |
Tiludronic-acid | hsa05215 | Prostate cancer | 4.81E-02 | 4 | P25963, P10415, Q12778, P08238 | NFKBIA, BCL2, FOXO1, HSP90AB1 | More | |
Tiludronic-acid | hsa05223 | Non-small cell lung cancer | 3.99E-02 | 4 | P17252, O43524, P19174, O75293 | PRKCA, FOXO3, PLCG1, GADD45B | More | |
Tiludronic-acid | hsa05231 | Choline metabolism in cancer | 3.99E-02 | 4 | P19174, P23743, O14494, P17252 | PLCG1, DGKA, PLPP1, PRKCA | More | |
Tiludronic-acid | hsa05323 | Rheumatoid arthritis | 1.82E-02 | 1 | Q9Y5K8 | ATP6V1D | More | |
Tiludronic-acid | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | |
Tiludronic-acid | hsa05415 | Diabetic cardiomyopathy | 2.64E-03 | 6 | P17252, P14598, Q15080, Q16718, O14521, P04406 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, GAPDH | More | |